Understanding the Genetic Risk of IDH-Mutant Glioma

N Engl J Med. 2023 Apr 6;388(14):1332-1334. doi: 10.1056/NEJMcibr2213112.

Authors

Tracy T Batchelor¹, Kyle M Walsh¹

Affiliation

¹ From the Department of Neurology, Brigham and Women's Hospital, Boston (T.T.B.); and the Department of Neurosurgery and Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC (K.M.W.).

PMID: 37018498
DOI: 10.1056/NEJMcibr2213112

No abstract available

MeSH terms

Brain Neoplasms* / genetics
Genetic Predisposition to Disease* / genetics
Glioma* / genetics
Humans
Isocitrate Dehydrogenase* / genetics
Mutation
Risk Factors

Substances

Isocitrate Dehydrogenase